为了获得访问"阿拉丁铁蛋"实时聊天框的流畅支持体验,建议您使用Chrome浏览器或选择360浏览器极速模式(如何切换极速模式?),感谢您选择我们!

3,5-二氨基-1,2,4-三氮唑

规格或纯度: ≥98%
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
D132247-5g
5g 现货 Stock Image
D132247-10g
10g 期货 Stock Image
D132247-25g
25g 现货 Stock Image
D132247-100g
100g 现货 Stock Image
D132247-500g
500g 现货 Stock Image
查看相关系列
三唑类 五元杂环化合物

基本描述

别名 胍唑
英文别名 AI3-51272|1,2,4-Triazolidine, 3,5-diimino-|Guanazole|MFCD00005233|NCI-C04819|3,5-DIAMINO-1,2,4-TRIAZOLE|FT-0691053|3,5-Diamino-1H-1,2,4-triazole|BIDD:GT0366|s-Triazole, 3,5-diamino-|DTXCID705367|AKOS000120421|NSC1895|NSC-1895|3,5-Diamino-1h-[1,2,4]triazol
规格或纯度 ≥98%
英文名称 3,5-Diamino-1,2,4-triazole
储存温度 充氩
运输条件 常规运输
产品介绍

DNA 合成抑制剂

Inhibitor of DNA synthesis.


Application:

3,5-Diamino-1,2,4-triazole is used as an inhibitor of DNA synthesis. It also serves as an antitumor agents in the treatment of epigenetically-based diseases. It acts as a corrosion inhibitor for copper.


名称和标识符

PubChem SID 488182061
EC号 215-937-2
IUPAC Name 1H-1,2,4-triazole-3,5-diamine
INCHI InChI=1S/C2H5N5/c3-1-5-2(4)7-6-1/h(H5,3,4,5,6,7)
InChi Key PKWIYNIDEDLDCJ-UHFFFAOYSA-N
Canonical SMILES C1(=NC(=NN1)N)N
Isomeric SMILES C1(=NC(=NN1)N)N
WGK Germany 3
RTECS XZ4535000
PubChem CID 15078
分子量 99.1
Beilstein号 112467
Reaxy-Rn 112467

化学和物理性质

溶解性 Soluble in water.
敏感性 空气敏感
熔点 202-205°C

安全和危险性(GHS)

象形图
ghs07

Harmful

信号词 Warning
危险声明 H315: Causes skin irritation
H319: Causes serious eye irritation
H302: Harmful if swallowed
H312: Harmful in contact with skin
H332: Harmful if inhaled
预防措施声明 P261,P305+P351+P338,P280,P302+P352,P321,P501,P264,P271,P270,P304+P340,P362+P364,P330,P264+P265,P301+P317,P317,P337+P317,P332+P317
WGK Germany 3
RTECS XZ4535000
Reaxy-Rn 112467
个人防护装备 dust mask type N95 (US), Eyeshields, Faceshields, Gloves

质检证书(COA)

质检报告(COA)

输入批号以搜索COA:

相关文档

质检报告COA

请输入批号:


相关技术文章

FAQ
用于合成生物活性化合物的1,2,4-三氮唑衍生物
1,2,4-Triazole Derivatives for Synthesis of Biologically Active Compounds

产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

参考文献

1. S K Carter,M Slavik.  (1977-03-01)  Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute..  National Cancer Institute monograph,    ((45)(45)):  (101-121).  [PMID:73134]
2. W H Lewis,J A Wright.  (1978-10-01)  Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells..  Journal of cellular physiology,  97  ((1)):  (87-97).  [PMID:568630]
3. G Tipples,G McClarty.  (1991-08-01)  Isolation and initial characterization of a series of Chlamydia trachomatis isolates selected for hydroxyurea resistance by a stepwise procedure..  Journal of bacteriology,  173  ((16)):  (4932-4940).  [PMID:1860812]
4. T Spector,T E Jones.  (1985-07-25)  Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors..  The Journal of biological chemistry,  260  ((15)):  (8694-8697).  [PMID:2991215]
5. E C Moore,R B Hurlbert.  (1985-01-01)  The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY)..  Pharmacology & therapeutics,  27  ((2)):  (167-196).  [PMID:3898152]
6. S Krauss,L E Broder,R Birch.  (1986-07-01)  Guanazole in the treatment of advanced bronchogenic carcinoma: a pilot study of the Southeastern Cancer Study Group..  Cancer treatment reports,  70  ((7)):  (913-914).  [PMID:3719585]
7. A Sato,P E Bacon,J G Cory.  (1984-01-01)  Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit..  Advances in enzyme regulation,  22  ():  (231-241).  [PMID:6089512]
8. R G Hards,J A Wright.  (1983-02-01)  A series of N-carbamoyloxyurea resistant cell lines with alterations in ribonucleotide reductase: lack of coordination in pyrimidine and purine reductase activity..  Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire,  61  ((2-3)):  (120-129).  [PMID:6342725]
9. R G Hards,J A Wright.  (1981-02-01)  N-carbamoyloxyurea-resistant Chinese hamster ovary cells with elevated levels of ribonucleotide reductase activity..  Journal of cellular physiology,  106  ((2)):  (309-319).  [PMID:7012160]
10. J G Cory,A Sato,L Lasater.  (1980-01-01)  Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy..  Advances in enzyme regulation,  19  ():  (139-150).  [PMID:7039256]
11. I K Larsen,B M Sjöberg,L Thelander.  (1982-06-15)  Characterization of the active site of ribonucleotide reductase of Escherichia coli, bacteriophage T4 and mammalian cells by inhibition studies with hydroxyurea analogues..  European journal of biochemistry,  125  ((1)):  (75-81).  [PMID:7049700]
12. A A Alhaider,C D Selassie,S O Chua,E J Lien.  (1982-01-01)  Measurements of ionization constants and partition coefficients of quanazole prodrugs..  Journal of pharmaceutical sciences,  71  ((1)):  (89-94).  [PMID:7057389]
13. C Dias Selassie,E J Lien,T A Khwaja.  (1981-11-01)  Synthesis and evaluation of guanazole prodrugs as antineoplastic agents..  Journal of pharmaceutical sciences,  70  ((11)):  (1281-1283).  [PMID:7299678]
14. Santana L et al..  (2008)  Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors..  J Med Chem,  51  (21):  (6740-51).  [PMID:18834112]
15. V M Kolb,J P Dworkin,S L Miller.  (1994-01-01)  Alternative bases in the RNA world: the prebiotic synthesis of urazole and its ribosides..  Journal of molecular evolution,  38  ():  (549-557).  [PMID:11539446]
16. L Guennoun,J El jastimi,F Guédira,K Marakchi,O K Kabbaj,A El Hajji,S Zaydoun.  (2010-11-30)  Molecular geometry and vibrational studies of 3,5-diamino-1,2,4-triazole using quantum chemical calculations and FT-IR and FT-Raman spectroscopies..  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,  78  ((1)):  (347-353).  [PMID:21112810]
17. C Loganathan,S Abraham John.  (2016-11-07)  Naked eye and spectrophotometric detection of chromogenic insecticide in aquaculture using amine functionalized gold nanoparticles in the presence of major interferents..  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,  173  ():  (837-842).  [PMID:27816882]
18. G R Gale,L M Atkins,S J Meischen,P Schwartz.  (1979-03-01)  Schedule-dependency assessments of ribonucleoside diphosphate reductase inhibitors when used in combination with platinum compounds plus cyclophosphamide in the treatment of advanced L1210 leukemia..  Cancer treatment reports,  63  ((3)):  (449-456).  [PMID:427825]
19. C Dave,M A Paul,Y M Rustum.  (1978-01-01)  Studies on the selective toxicity of guanazole in mice..  European journal of cancer,  14  ((1)):  (33-40).  [PMID:624301]
20. W Suter,F Romagna.  (1990-08-01)  DNA repair induced by various mutagens in rat hepatocyte primary cultures measured in the presence of hydroxyurea, guanazole or aphidicolin..  Mutation research,  231  ((2)):  (251-264).  [PMID:2117252]
21. M A Wani,R M Snapka.  (1990-01-01)  Drug-induced loss of unstably amplified genes..  Cancer investigation,  ((6)):  (587-593).  [PMID:2292052]
22. T Spector.  (1985-01-01)  Inhibition of ribonucleotide reductases encoded by herpes simplex viruses..  Pharmacology & therapeutics,  31  ((3)):  (295-302).  [PMID:3035588]
23. V A Filov,G I Kulik.  (1983-01-01)  [Pharmacokinetics of antitumor drugs]..  Voprosy onkologii,  29  ((7)):  (3-13).  [PMID:6410584]
24. J G Cory,L Lasater,A Sato.  (1981-05-01)  Effect of iron-chelating agents on inhibitors of ribonucleotide reductase..  Biochemical pharmacology,  30  ((9)):  (979-984).  [PMID:6786297]
25. J A Wright,R G Hards,J E Dick.  (1980-01-01)  Studies of mammalian ribonucleotide reductase activity in intact permeabilized cells: a genetic approach..  Advances in enzyme regulation,  19  ():  (105-127).  [PMID:7039254]
26. J T Trevors.  (1997-03-01)  Evolution of bacterial genomes..  Antonie van Leeuwenhoek,  71  ((3)):  (265-270).  [PMID:9111921]
27. L Guennoun,S Zaydoun,J El Jastimi,K Marakchi,N Komiha,O K Kabbaj,A El Hajji,F Guédira.  (2012-08-29)  Molecular structure and vibrational study of diprotonated guanazolium using DFT calculations and FT-IR and FT-Raman spectroscopies..  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,  97  ():  (975-985).  [PMID:22925973]
28. Srinivasan Kesavan,M Amal Raj,S Abraham John.  (2016-01-01)  Formation of electrochemically reduced graphene oxide on melamine electrografted layers and its application toward the determination of methylxanthines..  Analytical biochemistry,  496  ():  (14-24).  [PMID:26717896]